NCT00860704View on ClinicalTrials.gov

Goal Directed Fluid Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Goal Directed Fluid Therapy
Interventions
DRUG

fluidotherapy with ringer-lactate

a bolus of 250ml ringer-lactate is administered, if there is fluid demand monitored by the Esophageal Doppler

Trial Locations (1)

1090

Medical University Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT00860704 - Goal Directed Fluid Therapy | Biotech Hunter | Biotech Hunter